Abstract
In this commentary, I review recent advances in Alport syndrome genetics, diagnostics, and therapeutics. I also offer some opinions regarding strategies to optimize the early identification of affected individuals to promote early therapeutic intervention.
Original language | English (US) |
---|---|
Article number | 50 |
Journal | F1000Research |
Volume | 6 |
DOIs | |
State | Published - 2017 |
Bibliographical note
Publisher Copyright:© 2017 Kashtan C.
Keywords
- Alport syndrome
- COL4A3
- COL4A4
- COL4A5
- Collagen IV alpha-345 network
- End-stage renal disease